Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective, randomized, placebo-controlled trial of azithromycin after lung transplantation
2012-003331-32Phase 4Completed
- Sponsor
- KU Leuven
- Start
- Nov 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in Lung allograft rejection (LAR), Cardiac Rejection and airway morbidity comparing Azithromycin prophylaxis with Placebo control (2 arms). Primary endpoint: Mean pulmonary function (FEV1; % predicted) during the first 3 months after lung transplantation. Started Nov 2012; status: completed.
02
Drugs
azithromycin
03
Conditions
Lung allograft rejection (LAR)Cardiac Rejectionairway morbidity
Beyond the preview
Go deeper on 2012-003331-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-003331-32.